Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03340350 · ClinicalTrials.gov registry record · Phase 4
Minocycline for Treatment of Posttraumatic Stress Disorder in Veterans
A Phase 4 study of PTSD, sponsored by Sriram Ramaswamy.
- Completed
- Registry status
- Phase 4
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT03340350: Completed Phase 4 study of PTSD, sponsored by Sriram Ramaswamy.
NCT03340350 is a Phase 4 study of PTSD that has completed, run by Sriram Ramaswamy. The registered enrollment target is 10 participants, below the 302-participant average among 154 other PTSD trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03340350, a Phase 4 study of PTSD, has completed, sponsored by Sriram Ramaswamy.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The study will evaluate the safety and efficacy of adjunctive minocycline treatment in veterans with PTSD.
Primary Outcome
PTSD symptom severity was assessed using total scores on the Past Month version of the Clinician-Administered PTSD Scale for Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (CAPS-5). Total scores on the CAPS-5 range from 0 to 80, with higher scores indicating greater severity of PTSD symptoms.
Conditions Studied
Interventions
- DRUG Minocycline
Study Locations (1)
Nebraska
- VA Nebraska-Western Iowa Health Care System - Omaha
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2017-05-10 |
| Est. Completion | 2018-06-01 |
| Phase | Phase 4 |
What the finished NCT03340350 record still lists
NCT03340350 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 302-participant average among 154 other PTSD trials with a reported enrollment target (97% lower).
The record links to 1 condition, with PTSD appearing as the primary indexed condition, and to 1 intervention - of which Minocycline is the first listed.
NCT03340350 reports a single indexed study location in Nebraska.
Frequently Asked Questions
What is clinical trial NCT03340350 about?
NCT03340350 is a clinical study titled "Minocycline for Treatment of Posttraumatic Stress Disorder in Veterans". The study will evaluate the safety and efficacy of adjunctive minocycline treatment in veterans with PTSD.
What is the current status of trial NCT03340350?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 10 participants. The study started on 2017-05-10. Estimated completion is 2018-06-01.
What conditions does trial NCT03340350 study?
This clinical trial studies the following conditions: PTSD.
What interventions are being tested in trial NCT03340350?
The interventions under investigation include: Minocycline (DRUG).
Who is sponsoring clinical trial NCT03340350?
This trial is sponsored by Sriram Ramaswamy, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03340350 being conducted?
This trial has 1 study location across Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for PTSD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03340350's enrollment target sits among peer trials
10 150th of 154 higher than 3 of 154 other PTSD trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other PTSD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Effect of Outpatient Ketamine Infusion on Chronic Neuropathic Pain and PTSD
RECRUITING · Phase 4
-
Topiramate in the Treatment of Post Traumatic Stress Disorder (PTSD)
COMPLETED · Phase 4
-
Paroxetine Treatment in Outpatients With Comorbid PTSD and Substance Dependence
COMPLETED · Phase 4
-
Effects of Escitalopram on Autonomic Reactivity in Post Traumatic Stress Disorder
COMPLETED · Phase 4
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
Treatments for Insomnia in Veterans With PTSD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI